Ernexa Therapeutics Inc. (ERNA) stock
ERNANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ERNAW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$1.62−0.01 (-0.61%)
Close on Nov 18, 2026Market cap $2.64MP/E –Yield –
Ernexa Therapeutics shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Ernexa Therapeutics's shares outstanding was 1M at Jun 30, 2026. For fiscal 2025 it was 6M, up 593.1% from the year before. Over ten years it grew -5.4% a year on average. The highest annual figure on record is 15M in fiscal 2017.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 6M | +593.1% |
| FY2024 | Dec 31, 2024 | 1M | -82.9% |
| FY2023 | Dec 31, 2023 | 5M | +74.2% |
| FY2022 | Dec 31, 2022 | 3M | +40.9% |
| FY2021 | Dec 31, 2021 | 2M | +2.6% |
| FY2020 | Dec 31, 2020 | 2M | +12135.1% |
| FY2019 | Dec 31, 2019 | 0M | +7.0% |
| FY2018 | Dec 31, 2018 | 0M | -99.9% |
| FY2017 | Dec 31, 2017 | 15M | +28.3% |
| FY2016 | Dec 31, 2016 | 11M | +3.5% |
| FY2015 | Dec 31, 2015 | 11M | +104828.6% |
| FY2014 | Dec 31, 2014 | 0M | -99.9% |
| FY2013 | Dec 31, 2013 | 9M | +4.2% |
| FY2012 | Dec 31, 2012 | 8M | +114204.6% |
| FY2011 | Dec 31, 2011 | 0M | -99.9% |
| FY2010 | Dec 31, 2010 | 7M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 1M | +471.5% |
| Q1 FY2026 | Mar 31, 2026 | 1M | +457.7% |
| Q4 FY2025 | Dec 31, 2025 | 8M | +2187.3% |
| Q3 FY2025 | Sep 30, 2025 | 8M | +2178.7% |
| Q2 FY2025 | Jun 30, 2025 | 0M | -96.2% |
| Q1 FY2025 | Mar 31, 2025 | 0M | -97.4% |
| Q3 FY2024 | Sep 30, 2024 | 0M | -93.3% |
| Q2 FY2024 | Jun 30, 2024 | 0M | -93.2% |
| Q1 FY2024 | Mar 31, 2024 | 5M | +5.5% |
| Q4 FY2023 | Dec 31, 2023 | 5M | +48.7% |
| Q3 FY2023 | Sep 30, 2023 | 5M | +84.0% |
| Q2 FY2023 | Jun 30, 2023 | 5M | +80.4% |
| Q1 FY2023 | Mar 31, 2023 | 5M | +91.2% |
| Q4 FY2022 | Dec 31, 2022 | 4M | +39.6% |
| Q3 FY2022 | Sep 30, 2022 | 3M | +16.4% |
| Q2 FY2022 | Jun 30, 2022 | 3M | -93.1% |
| Q1 FY2022 | Mar 31, 2022 | 3M | +9544.2% |
| Q4 FY2021 | Dec 31, 2021 | 3M | -85.2% |
| Q3 FY2021 | Sep 30, 2021 | 3M | -85.6% |
| Q2 FY2021 | Jun 30, 2021 | 42M | +142.5% |
| Q1 FY2021 | Mar 31, 2021 | 0M | +60.3% |
| Q3 FY2020 | Sep 30, 2020 | 18M | +102119.9% |
| Q2 FY2020 | Jun 30, 2020 | 18M | +2.1% |
| Q1 FY2020 | Mar 31, 2020 | 18M | +1.8% |
| Q4 FY2019 | Dec 31, 2019 | 0M | -99.9% |
| Q3 FY2019 | Sep 30, 2019 | 0M | +14.3% |
| Q2 FY2019 | Jun 30, 2019 | 17M | +114242.6% |
| Q1 FY2019 | Mar 31, 2019 | 17M | +14.1% |
| Q3 FY2018 | Sep 30, 2018 | 17M | +14.1% |
| Q2 FY2018 | Jun 30, 2018 | 0M | -99.9% |
| Q1 FY2018 | Mar 31, 2018 | 0M | -99.9% |
| Q4 FY2017 | Dec 31, 2017 | 15M | +19.9% |
| Q3 FY2017 | Sep 30, 2017 | 15M | +136115.3% |
| Q2 FY2017 | Jun 30, 2017 | 15M | – |
| Q1 FY2017 | Mar 31, 2017 | 14M | – |
| Q4 FY2016 | Dec 31, 2016 | 13M | – |
| Q3 FY2016 | Sep 30, 2016 | 0M | – |
See a number that looks wrong?